NCT01620333
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Clinical trial condition
Diabetes
Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.
2,489 public trials
175 recruiting studies
Diabetes trial results
Completed
Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects
NCT01520831
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany
NCT01467323
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Graz, Austria
- Novo Nordisk Investigational Site Vienna, Austria
- Novo Nordisk Investigational Site Anklam, Germany
- Novo Nordisk Investigational Site Berlin, Germany
NCT01705639
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Botniacentret Jakobstad Jakobstad, Finland
- Vasa health care centre Vaasa, Finland
NCT00095446
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Princeton, New Jersey, United States
NCT02557620
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
NCT01707160
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Leeds, United Kingdom
Completed
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
NCT01520818
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Aalst, Belgium
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Edegem, Belgium
NCT01520753
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
Completed
Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes
NCT01697618
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Alphen aan den Rijn, Netherlands
- Novo Nordisk Investigational Site Crawley, United Kingdom